Abstract submission portal for the "24th Global Meet on Cancer Research and Oncology" is open now. To submit your abstract for presentation at this event, visit- Cancer Conferences Abstract Submission
Tuesday, 17 July 2018
Tuesday, 10 July 2018
26th Annual Congress on Cancer Science and Targeted Therapies October 29-30, 2018 San Francisco, California, USA; International Conference on Gastrointestinal Cancer and Therapeutics October 29-30, 2018 San Francisco, California, USA; International Conference on Robotic Oncology October 26-27, 2018 Osaka, Japan; 36th World Cancer Conference October 11-13, 2018 Zurich, Switzerland; International Conference on Cancer Science & Robotics August 1-2, 2018 Melbourne, Australia; 5th World Congress on Epigenetics and Chromosome October 22-24, 2018 Turkey; Euro Breast Cancer Summit October 18-19, 2018 | Amsterdam, Netherlands; Annual Congress on Cancer and Stem Cell Research October 17-18, 2018 New York, USA; 22nd World Conference on Liquid Biopsy & Biomarkers October 15-16, 2018 Toronto, Canada; International Conference on Molecular Markers and Cancer Therapeutics October 8-9, 2018 Dubai, UAE; International Conference on Cancer Diagnosis& Treatment August 2-3 2018 Oslo, Norway; 12th World Congress on Biomarkers & Clinical Research October 03-04, 2018 Los Angeles, California, USA; ESMO Asia Congress. RCE-ESMO-ESO Training Course for Rare Cancer Patient Advocates. ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers. ESMO Congress.
Friday, 6 July 2018
"24th Global Meet on Cancer Research and Oncology" is now accepting abstract under the category "Biomarkers in Cancer Research".
To submit your abstracts, visit- Cancer Conferences Abstract Submission
Cancer Conferences | Biomarkers Conferences | Oncology Conferences | Events |
Canada | Toronto
Canada | Toronto
Wednesday, 4 July 2018
We are now accepting the abstracts for presentation at the "24th Global Meet on Cancer Research and Oncology"- Toronto. To submit your abstract for the conference, please visit: Abstract Submission- Cancer Pharmacology Conferences
Global Summit on Oncology & Cancer Singapore; 2nd International Conference on Cancer Genetics and Epigenetics; 22nd Global Annual Oncologists Meeting ; World Haematology and Medical Oncology Conference ; Global Meeting on Oncology and Radiology June 1-2, 2018 Osaka, Japan; Cancer Genomics Conference: New Era for Cancer Prevention June 25-26, 2018 Dubai, UAE; World Cancer Summit 2018 July 02-03, 2018 Bangkok, Thailand; International Conference on Biomarkers and Cancer Targets July 16-17, 2018 Dubai, UAE; 4th Annual Conference on Preventive Oncology July 18-19, 2018 Atlanta, Georgia, USA; 4th Annual Conference on Gynaecologic Oncology and Reproductive Disorders July 18-19, 2018 Atlanta, Georgia, USA; 29th Euro-Global Summit on Cancer Therapy & Radiation Oncology July 23-25, 2018 Rome, Italy; Experts Meet On Cancer Therapy 2018 July 23-24, 2018 Melbourne, Australia.
Wednesday, 27 June 2018
24th Global Meet on Cancer Research and oncology is now accepting abstracts under the category "Cancer Nursing". To submit your abstracts under this category, visit: Abstract Submission- Cancer Conferences
Cancer Conferences | Nursing Conferences | Cancer Nursing | Cancer Science Conferences | Cancer Therapy Conferences | Toronto Conferences | Canada Conferences on Cancer | Medicine Conferences | Meetings | Summit | Oncology Conferences
Tuesday, 26 June 2018
Report: New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments. This patient received the treatment in a clinical trial led by Steven A. Rosenberg, M.D., Ph.D., chief of the Surgery Branch at NCI’s Center for Cancer Research (CCR), and the findings were published June 4, 2018 in . NCI is part of the National Institutes of Health.
“We’ve developed a high-throughput method to identify mutations present in cancer that are recognized by the immune system,” Dr. Rosenberg said. “This research is experimental right now. But because this new approach to immunotherapy is dependent on mutations, not on cancer type, it is in a sense a blueprint we can use for the treatment of many types of cancer.”
The new immunotherapy approach is a modified form of adoptive cell transfer (ACT). ACT has been effective in treating melanoma, which has high levels of somatic, or acquired, mutations. However, it has been less effective with some common epithelial cancers, or cancers that start in the lining of organs, that have lower levels of mutations, such as stomach, esophageal, ovarian, and breast cancers.
Thursday, 21 June 2018
The number of elderly people being diagnosed with cancer is set to rise by 80% over the next two decades, experts have warned.
About 130,000 people over the age of 75 currently get some form of the disease in the UK each year, but Cancer Research UK has predicted that it could soar to 234,000 by 2035 as a result of an aging population.
With a significant gap in survival rates between Britain and the world's best-performing countries when it comes to older cancer patients, the charity has called on the NHS to do more to ensure it is prepared for the major increase.
Head information nurse Martin Ledwick said: "When elderly people have a lot of health problems and are taking a range of different medications, it can affect what treatment they are able to receive.
"Some older people with cancer might not be fit enough to have surgery and go through lengthy periods of chemotherapy and radiotherapy, but as no two patients are the same, there will be others who are.
"That's why it's so important staff are well trained and resourced so they can assess older people properly and ensure they receive the right treatment, care and support specific to their individual needs."
Women who get breast cancer above the age 75 are far more likely to survive for longer in Europe than they are in the UK and Ireland, and survival rates for bowel cancer in the same age group are 15% lower here than in Canada.
The report suggested the rates were notably lower among older patients in the UK because they were more likely to be diagnosed with cancer at a more advanced stage, making it harder to treat.
Between 2006 and 2015, 41% of all cancers in those aged 80 to 84 were diagnosed in an emergency in England, compared with 14% of cancers in those aged between 50 and 59.
Rose Gray, Cancer Research UK's policy manager, added: "If we do nothing, the disparity in care between older and younger cancer patients will only grow.
"It's vital to address this if we want to realize our ambition of ensuring world-class treatment for everyone in the UK who is affected by cancer."